Moderna
MRNA
MRNA
771 hedge funds and large institutions have $27.4B invested in Moderna in 2021 Q1 according to their latest regulatory filings, with 168 funds opening new positions, 289 increasing their positions, 223 reducing their positions, and 102 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
771
Holders Change
+58
Holders Change %
+8.13%
% of All Funds
13.58%
Holding in Top 10
17
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+30.77%
% of All Funds
0.3%
New
168
Increased
289
Reduced
223
Closed
102
Calls
$2.01B
Puts
$2.37B
Net Calls
-$360M
Net Calls Change
+$123M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$2.75B |
| 2 |
Morgan Stanley
New York
|
+$318M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$307M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$238M |
| 5 |
Coatue Management
New York
|
+$165M |
Top Sellers
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$1.35B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$583M |
| 3 |
D.E. Shaw & Co
New York
|
-$400M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$286M |
| 5 |
RWA
Ropes Wealth Advisors
Boston,
Massachusetts
|
-$202M |
